Stagflation stocks

Upstream oil major that directly benefits from higher crude prices and risk premiums.

Exxon Mobil acts as a structural inflation hedge. Rising energy costs, which are a primary driver of the reported inflation spike, translate into windfall profits for integrated oil majors that possess low-cost production assets and global scale.

As an integrated energy major, ExxonMobil benefits from the 7.8% surge in energy PPI. Their business model captures higher margins from elevated crude and refined product prices (gasoline and diesel) while acting as a hedge against broader inflationary shocks.

An energy-led upside CPI outcome would reinforce higher crude and fuel-price realizations. Exxon Mobil, as a major crude producer, has positive revenue and earnings sensitivity to higher oil and fuel prices, although a rate-driven demand slowdown could temper the benefit.

EOG Resources is a premier U.S. upstream producer with unhedged crude production and a low-cost base, allowing it to act as the cleanest spot-capture beneficiary of escalating Brent/WTI crude prices.

EOG Resources, Inc., together with its subsidiaries, explores for, develops, produces, and markets crude oil, natural gas liquids, and natural gas in producing basins in the United States, the Republic of Trinidad and Tobago, and internationally. The company also offers crude oil and condensate, and gathering, processing and marketing. The company was formerly known as Enron Oil & Gas Company. EOG Resources, Inc. was incorporated in 1985 and is headquartered in Houston, Texas.

CF Industries captures wide profit margins from a geographical feedstock arbitrage. Utilizing low-cost North American pipeline gas, its input costs are protected from Middle East energy price spikes, while global nitrogen fertilizer prices remain high due to energy and shipping disruptions.

Diamondback Energy is an upstream producer with direct exposure to rising commodity prices driven by geopolitical conflict, leading to higher margins and free cash flow.

Diamondback is a direct beneficiary of the surge in producer prices, particularly energy costs. As a U.S.-focused upstream producer, it benefits from high crude oil prices driven by Middle East geopolitical risks without experiencing operational disruption from the conflict. The company estimates that $90/bbl oil supports high free cash flow yields, which increase significantly at $110/bbl.

Upstream producer with extreme sensitivity to crude prices for annual cash flow generation.

ConocoPhillips is a largely upstream oil and gas producer, so higher global crude benchmarks directly improve realized prices, revenue, and cash flow when conflict-related supply scarcity persists.

P&G's essential household products and pricing power provide better cost recovery than discretionary consumer categories, though petroleum inputs remain a headwind.

Procter & Gamble produces essential consumer staples, which enjoy inelastic demand and pricing power. During stagflationary periods (indicated by high Prices Paid and contracting services employment), investors favor defensive names like PG over higher-multiple growth stocks or highly cyclical consumer discretionary companies.

The Procter & Gamble Company, commonly referred to as P&G, is a global enterprise that supplies a broad spectrum of branded consumer products to markets worldwide. The company's operations are divided into five main business divisions: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers an assortment of hair care products, including conditioners, shampoos, styling aids, and treatments, under popular names like Head & Shoulders, Herbal Essences, Pantene, and Rejoice. It also features antiperspirants, deodorants, personal cleansing solutions, and skin care items from brands such as Olay, Old Spice, Safeguard, Secret, and SK-II. Within the Grooming division, P&G provides a range of shave care products and grooming appliances, prominently featuring brands like Braun, Gillette, and Venus. The Health Care unit encompasses oral hygiene essentials, including toothbrushes, toothpastes, and other dental care products sold under the Crest and Oral-B brand names. This segment further extends to gastrointestinal remedies, rapid diagnostics, respiratory care, vitamins/minerals/supplements, pain relief, and various other personal health care items from brands such as Metamucil, Neurobion, Pepto-Bismol, and Vicks. In the Fabric & Home Care category, consumers find fabric enhancers, laundry additives, and laundry detergents through labels like Ariel, Downy, Gain, and Tide. Additionally, this division offers air care products, dishwashing solutions, professional cleaning supplies (P&G Professional), and surface cleaners, exemplified by brands such as Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer. Finally, the Baby, Feminine & Family Care segment provides infant care products, including baby wipes, taped diapers, and pants, under the Luvs and Pampers brands. It also supplies adult incontinence and feminine hygiene products from Always, Always Discreet, and Tampax, along with paper towels, tissues, and toilet paper marketed as Bounty, Charmin, and Puffs. P&G distributes its extensive product portfolio through a vast commercial network, including large retail chains, e-commerce platforms, grocery stores, membership clubs, pharmacies, department stores, various distributors, wholesalers, specialty beauty retailers, high-frequency stores, electronics outlets, and professional channels, as well as direct-to-consumer sales. The Procter & Gamble Company was established in 1837 and its corporate headquarters are located in Cincinnati, Ohio.

Coca-Cola’s branded beverages are everyday consumer products with essentiality and brand loyalty that support demand and pricing power relative to discretionary goods.

Coca-Cola can face higher logistics and supply-chain costs, while brand strength and essential demand provide some pass-through protection.

A sticky PCE reading can shift demand toward essential, branded consumer products relative to discretionary categories. Coca-Cola has brand loyalty and pricing power that can help preserve demand and offset some input-cost inflation, although logistics and supply-chain costs remain a headwind.

Direct commodity exposure allows revenue to reset instantly with global market prices, effectively passing all inflationary upside to the top line.

As a major producer of copper and gold, Freeport-McMoRan benefits directly from the appreciation of commodity prices, which typically rise in tandem with inflationary spikes. Copper specifically serves as a hedge due to its critical role in infrastructure and energy transition.

Healthcare REITs utilize annual lease resets that track inflation (CPI-linked), providing a formal mechanism for pass-through.

As a healthcare REIT, Welltower benefits from structural rent growth that tracks living costs. REITs in the residential and healthcare sectors can reprice leases annually, allowing them to pass on inflationary pressures to tenants more effectively than other property sectors.

Royal Gold is an asset-light royalty and streaming company. The Gold Fields result supports a positive read-through because higher metal prices and stronger producer cash flows improve royalty-sector economics and can increase the pool of financially capable counterparties seeking mine-development capital, without Royal Gold bearing direct mine operating costs.

Valero has high pass-through resilience because its refining margins are supported by product scarcity and its feedstock costs are reflected in product pricing.

Valero is an independent refiner with no upstream operations, making it a pure play on refining margins. Tight global supplies and high fuel prices have driven record-high crack spreads, allowing Valero to capture outsized operating profits.

The CPI release reported a 3.9% monthly gasoline increase and a 2.1% energy increase. If elevated refined-product prices persist, Valero can benefit from higher refining margins and crack spreads, increasing refining revenue and operating profit.

Resilience comes from medical necessity rather than consumer value-seeking.

As a major provider of medical consumables like needles and syringes, BDX remains resilient to shifts in consumer sentiment because hospital and patient demand for essential medical supplies is non-discretionary.

Staple household products are relatively defensive and may benefit from consumers trading down from discretionary categories, although lower incomes can still pressure volumes and mix.

Unilever's essential consumer-staples demand is relatively resilient when weaker employment causes households to reduce discretionary purchases. Potential rate easing can also lower the discount rate applied to defensive cash flows, although weaker household incomes may increase trading-down and volume pressure.

Unilever Plc engages in the manufacture and sale of consumer goods. It operates through the following segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment offers hair care, skin care, and prestige beauty and health & wellbeing. The Personal Care segment consists of sales of skin cleansing, deodorant, and oral care products. The Home Care segment comprises of sales of fabric care and a wide range of cleaning products. The Nutrition segment refers to sales of scratch cooking aids, dressings, and tea products. The Ice Cream segment covers primarily ice cream products. The company was founded by Antonius Johannes Jurgens, Samuel van den Bergh, and William Hulme Lever in 1930 and is headquartered in London, the United Kingdom.

Sells necessary transportation fuels, which are highly inelastic and insulated from discretionary wallet-share contraction.

Marathon Petroleum is directly exposed to refined-product prices and crack spreads, making it a high-leverage beneficiary of energy inflation.

The CPI preview identifies energy and gasoline prices as major headline drivers. If elevated refined-product prices persist, Marathon Petroleum can benefit from wider gasoline, diesel and jet-fuel crack spreads and higher refined-product revenue, although weaker transportation demand and crude costs could offset part of the gain.

EQT is a major upstream producer whose revenues are positively tied to rising natural gas prices.

EQT Corporation primarily functions as an extractor of natural gas within the United States. In addition to natural gas, the firm also obtains various natural gas liquids (NGLs), specifically ethane, propane, isobutane, butane, and natural gasoline. By the end of 2021, EQT possessed certified reserves amounting to 25.0 trillion cubic feet of natural gas, NGLs, and crude oil. These reserves are situated across roughly 2.0 million gross acres, with a significant 1.7 million gross acres located within the Marcellus shale formation. The company, which dates back to its founding in 1878, has its principal offices in Pittsburgh, Pennsylvania.

ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.

Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.

Sanofi is a global healthcare enterprise dedicated to the research, development, manufacturing, and commercialization of therapeutic solutions across the United States, Europe, and other international markets. Its business is structured into three primary divisions: Pharmaceuticals, Vaccines, and Consumer Healthcare. The Pharmaceuticals segment delivers specialized treatments, encompassing human monoclonal antibodies and therapies for a range of conditions such as multiple sclerosis, neurological disorders, various inflammatory and immunological diseases, rare disorders, oncology, and rare blood conditions. This division also provides medications for diabetes, cardiovascular health, and a portfolio of established prescription drugs. Through its Vaccines division, Sanofi supplies crucial immunizations, including pediatric vaccines for diseases like poliomyelitis, pertussis, and Hib, alongside adult vaccines addressing influenza, booster needs, meningitis, and those required for travel or endemic regions. The Consumer Healthcare portfolio features over-the-counter remedies for common ailments such as allergies, coughs and colds, and pain relief. It also includes products for liver care, general physical and mental wellness, probiotics, digestive health, and nutritional support. Additionally, this segment offers personal care items like daily body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and powders for eczema. Sanofi maintains an active pipeline with numerous pharmaceutical products and vaccines currently undergoing various stages of development. The company has forged strategic alliances, including a collaboration with GlaxoSmithKline for the development of a recombinant Covid-19 vaccine, a research partnership with Stanford University School of Medicine aimed at advancing immunology and inflammation knowledge, and a collaboration and license option agreement with Prellis Biologics, Inc. Founded in 1973 and headquartered in Paris, France, the company operated as Sanofi-Aventis before rebranding to Sanofi in May 2011.

United Therapeutics Corporation, a biotechnology firm, is dedicated to discovering, developing, and bringing to market medical solutions for individuals suffering from chronic and severe, often life-threatening, illnesses. Its operations span both the United States and international markets. The company's current commercial portfolio features several key therapeutics: Remodulin, prescribed for pulmonary arterial hypertension (PAH) to lessen symptoms experienced during physical activity. Tyvaso, an inhaled form of the prostacyclin analogue treprostinil, designed to enhance exercise capacity in patients with PAH and pulmonary hypertension linked to interstitial lung disease (PH-ILD). Orenitram, a treprostinil tablet formulation, also aims to boost the exercise capabilities of PAH patients. Unituxin, a monoclonal antibody utilized in the treatment of high-risk neuroblastoma. Adcirca, an oral PDE-5 inhibitor, which helps improve exercise performance in those with PAH. United Therapeutics also maintains a robust development pipeline, including: Tyvaso DPI, a dry powder inhaler version of Tyvaso. The Remunity Pump, a compact, lightweight, and durable infusion system for treprostinil, accompanied by a separate controller. RemoPro and Ralinepag, both investigational treatments for PAH. Aurora-GT, a gene therapy product focused on regenerating blood vessels within the lungs. Clinical trials such as Tyvaso PERFECT and TETON, which are evaluating Tyvaso's efficacy in patients with World Health Organization (WHO) Group 3 pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD). The company has forged strategic alliances and licensing agreements with various entities, such as DEKA Research & Development Corp. for a semi-disposable subcutaneous treprostinil delivery system; MannKind Corporation for the development and licensing of treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. for the development of Ralinepag. Established in 1996, United Therapeutics Corporation is headquartered in Silver Spring, Maryland.

Merck KGaA is a German science and technology company with operations divided into three core segments: Life Science, Healthcare, and Electronics. The Life Science division supplies essential tools, chemicals, and equipment to academic research institutions, biotechnology firms, pharmaceutical manufacturers, and various industrial sectors. It also offers specialized process development expertise, such as continuous bioprocessing for drug manufacturers, provides a range of testing kits, reagents, and services, and develops solutions for analyzing environmental samples like air, water, and soil. Furthermore, this segment aids in assessing nutritional value and identifying quality control issues. In its Healthcare segment, the company is involved in the entire lifecycle of prescription drugs and biopharmaceuticals, from initial discovery and development through manufacturing and marketing. Its therapeutic focus areas include oncology, neurology and immunology, fertility, endocrinology, cardiovascular diseases, diabetes, thyroid disorders, and multiple sclerosis. This segment also produces general medicines, injection devices, and software for disease monitoring. The Electronics division delivers critical materials for the semiconductor and display industries. It also specializes in surface design, providing delivery systems and services, along with a variety of surface solutions for applications such as cosmetics, effect pigments, and other functional materials. Merck KGaA is also actively engaged in strategic partnerships. These include in-licensing agreements with Debiopharm International SA for developing treatments for head and neck cancer, with Jiangsu Hengrui Pharmaceuticals Co. Ltd. for metastatic colorectal cancer drug candidates, and with Abbisko Therapeutics Co. Ltd. for therapies targeting tenosynovial giant cell tumors. Additionally, the company is involved in collaborations focused on discovering and developing targeted protein degraders against critical oncogenic proteins. Founded in 1668 and headquartered in Darmstadt, Germany, Merck KGaA operates as a subsidiary of E. Merck KG.

Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.

Church & Dwight Co., Inc. is a company dedicated to the creation, production, and marketing of a diverse portfolio encompassing household, personal care, and specialized industrial goods. Its operations are structured into three principal divisions: Consumer Domestic, Consumer International, and the Specialty Products Division. The company offers a broad array of well-known consumer brands. Under the ARM & HAMMER umbrella, it provides cat litters, carpet fresheners, laundry detergents, baking soda, and various other baking soda-based items. Sexual health products, including condoms, lubricants, and vibrators, are marketed under the TROJAN brand. OXICLEAN delivers stain removers, cleaning solutions, laundry detergents, and bleach alternatives. SPINBRUSH offers both battery-operated and manual toothbrushes. Home pregnancy and ovulation test kits are available through FIRST RESPONSE. NAIR specializes in depilatories, while ORAJEL provides oral pain relief. XTRA is another prominent laundry detergent brand. Gummy dietary supplements are sold under the L'IL CRITTERS and VITAFUSION labels. BATISTE is known for its dry shampoos. WATERPIK manufactures water flossers and replacement showerheads. The company also includes its FLAWLESS range of products, ZICAM for cold symptom relief, and THERABREATH for oral care. Beyond consumer items, Church & Dwight supplies specialty products. These include advanced animal productivity solutions such as MEGALAC, a rumen bypass fat supplement designed to help cows sustain energy during peak milk production. BIO-CHLOR and FERMENTEN are utilized to mitigate health issues linked to calving and to provide essential protein. CELMANAX is a refined functional carbohydrate and yeast-based prebiotic. Furthermore, the company furnishes sodium bicarbonate for industrial use, as well as various cleaning and deodorizing compounds. Church & Dwight distributes its consumer goods through an extensive network of retail outlets, including supermarkets, large department stores, wholesale clubs, drugstores, convenience stores, home goods stores, dollar and other discount retailers, pet stores, specialized shops, and various online e-commerce channels. Its specialty products, conversely, reach industrial clients and livestock producers via dedicated distributors. Founded in 1846, Church & Dwight Co., Inc. maintains its corporate headquarters in Ewing, New Jersey.

Crown has demonstrated strong pass-through of aluminum input inflation to brand owners, materially protecting operating margins.

Crown is directly affected by the new information. Q3 beverage-can shipments rose more than 6% and higher shipments helped offset input-cost inflation, but the company issued lower forward EPS guidance after the quarterly beat. The $405 million of higher material costs passed through in sales indicates that conversion margins and working capital remain exposed to input-cost timing.

Crown Holdings, Inc. is a global enterprise dedicated to the design, production, and sale of a diverse range of packaging solutions and related machinery. Its operations span the Americas, Europe, and Asia Pacific, serving both consumer and industrial markets. For consumer goods, the company offers steel and aluminum cans, primarily targeting the food and beverage sectors. Its consumer product portfolio further extends to include glass bottles for beverages, as well as steel crowns and aluminum caps. In the industrial segment, Crown Holdings provides products such as steel and plastic strap consumables and the necessary application equipment, paper-based protective packaging, and various plastic film consumables and associated machinery. These industrial solutions are vital to industries including metals, food and beverage, construction, agriculture, corrugated packaging, and general manufacturing. Additionally, the company supplies a comprehensive array of equipment and tools, from manual and semi-automatic to fully automatic systems. These are specifically engineered for end-of-line manufacturing applications, facilitating the efficient application of its industrial consumable products. Established in 1892, Crown Holdings, Inc. is headquartered in Yardley, Pennsylvania.

While energy costs are a major input for industrial gas producers, Linde possesses significant pricing power and uses surcharges to mitigate volatility. High energy prices also accelerate demand for their energy-efficient technologies.

Nestlé's packaged-food portfolio is exposed to food inflation and supply-chain costs; its premium brands provide partial pass-through but do not eliminate COGS risk.

Nestlé India should receive a positive read-through from stronger premium packaged-food and beverage demand, with revenue and volumes benefiting if consumers continue trading toward branded, higher-value products. Food inflation remains a potential COGS offset.

Nestlé India Limited operates as a leading manufacturer and distributor of food products throughout India. Its diverse offerings include a wide range of dairy and nutritional items, such as dairy whiteners, condensed and UHT milk, yogurts, specialized maternal and infant formulas, baby food, and healthcare nutrition products. The company also provides prepared meals and culinary aids like noodles, sauces, seasonings, pasta, and cereals. Its beverage segment features both instant powdered options, including coffee and tea, and ready-to-drink selections. Additionally, Nestlé India produces confectionery items, spanning bar countlines, tablets, and various sugar candies. Beyond its domestic market, the company actively exports its products globally. Incorporated in 1959, Nestlé India Limited maintains its headquarters in Gurugram, India.

Varun Beverages Limited (VBL) and its subsidiaries serve as a prominent franchisee for PepsiCo, overseeing the manufacturing, bottling, distribution, and sales of both carbonated and non-carbonated beverages under PepsiCo's diverse brand portfolio. The company's extensive range of sparkling drinks features well-known names such as Pepsi, Diet Pepsi, Seven-Up, Mirinda (Orange and Lemon), Mountain Dew, Seven-Up Nimbooz Masala Soda, Evervess Soda, Duke's Soda, Sting, Pepsi Black, Mountain Dew Ice, Slice Fizzy, and Teem. Additionally, VBL produces and distributes still beverages, including Tropicana Slice, Tropicana Juices, Seven-Up Nimbooz, Gatorade, and Quaker Oats Milk, alongside packaged water brands like Aquafina and Aquavess. In Sri Lanka, the company also holds the franchise for PepsiCo's Ole brand. VBL's products are delivered to retail outlets directly and through an extensive distributor network across India, Nepal, Sri Lanka, Morocco, Zambia, and Zimbabwe. Established in 1995, Varun Beverages Limited is based in Gurugram, India, and operates as a subsidiary of RJ Corp Limited.

SaaS models allow defensive tech companies to retain subscription pricing power to offset cost pressures.

Defensive technology software providers like Microsoft remain highly resilient under stagflationary cost pressures. They enjoy low direct input cost exposure, high recurring SaaS revenues, and strong subscription pricing power to offset inflation, making them attractive allocation options as service indices soften.

A hawkish CPI signal raises discount and investment hurdle rates for Microsoft's long-duration AI, cloud and data-center investments. Microsoft's strong cash generation limits refinancing stress, but higher capital costs can reduce the returns and free-cash-flow contribution of incremental infrastructure spending.